Results 11 to 20 of about 2,786 (199)

The pharmacology and therapeutic potential of (-)-huperzine A

open access: yesJournal of Experimental Pharmacology, 2012
Maung Kyaw Moe Tun, Seth B HerzonDepartment of Chemistry, Yale University, New Haven, CT, USAAbstract: (–)-Huperzine A (1) is an alkaloid isolated from a Chinese club moss.
Tun MK, Herzon SB
doaj   +6 more sources

Total Synthesis of (−)-Huperzine A [PDF]

open access: yesOrganic Letters, 2009
The total synthesis of huperzine Q was accomplished. The synthesis features the construction of the cis-hydrindane skeleton via a Diels-Alder reaction and a ring contraction reaction of an epoxyketone.
Toshimune Nomura   +2 more
core   +7 more sources

Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials.

open access: yesPLoS ONE, 2013
BackgroundHuperzine A is a Chinese herb extract used for Alzheimer's disease. We conducted this review to evaluate the beneficial and harmful effect of Huperzine A for treatment of Alzheimer's disease.MethodsWe searched for randomized clinical trials ...
Guoyan Yang   +3 more
doaj   +2 more sources

Examining the interactome of huperzine A by magnetic biopanning. [PDF]

open access: yesPLoS ONE, 2012
Huperzine A is a bioactive compound derived from traditional Chinese medicine plant Qian Ceng Ta (Huperzia serrata), and was found to have multiple neuroprotective effects.
Wei Guo   +8 more
doaj   +4 more sources

Synthetic approaches to huperzine A

open access: yes, 2018
The natural product huperzine A has been found to possess activity as a nootropic agent. Because of its memory facilitating effects, huperzine A represents a promising drug for the treatment of neurodegenerative diseases, such as Alzheimer's disease.
Vines, Danette
openaire   +3 more sources

Isolation and purification of Huperzine A

open access: yes浙江大学学报. 农业与生命科学版, 2002
Technique of isolation and purification of Huperzine A from Huperzia serrata (Thunb) Trev. was studied in this paper. To get rid of some pigments and other impurities, some of chemical techniques for separation such as extraction with organic acid ...
SHEN Sheng-rong   +3 more
doaj   +2 more sources

Divergent Total Synthesis of the Lycopodium Alkaloids Huperzine A, Huperzine B, and Huperzine U

open access: yes, 2016
Huperzine A, huperzine B, and huperzine U are congeners isolated from the Chinese herb Huperzia serrata (=Lycopodium serratum) in minuscule amounts. The most efficient total synthesis of huperzine A, the first asymmetric total syntheses of huperzine B ...
Bing-Feng Sun (1863463)   +4 more
core   +6 more sources

Neuroprotective Effects of Huperzine B and <i>Huperzia carinata</i> Extract Against MPP<sup>+</sup>-Induced Oxidative Stress in SH-SY5Y Cells. [PDF]

open access: yesAdv Pharmacol Pharm Sci
Parkinson’s disease (PD) is a neurodegenerative disorder associated with dopaminergic neuronal loss, mitochondrial dysfunction, and redox imbalance. Huperzine B (HupB), an alkaloid derived from Huperzia species, has demonstrated antioxidant and acetylcholinesterase‐inhibitory activity; however, its effects in toxin‐induced cellular models of ...
Viwatpinyo K   +6 more
europepmc   +2 more sources

Valorization of Ficus carica Pruning Residues as Selective Botanical Insecticides: Optimized Furanocoumarin Extraction, Efficacy Against Neotropical Stink Bugs, and Mechanistic Insights via Molecular Docking. [PDF]

open access: yesArch Insect Biochem Physiol
Optimized extracts from Ficus carica pruning waste exhibit strong biological activity against major stink bug pests. Complementary in silico analyses suggest this efficacy relies on pest‐specific acetylcholinesterase inhibition, predicting a promising, pollinator‐safe alternative for sustainable agriculture.
Almeida TA   +7 more
europepmc   +2 more sources

Natural Chiral Scaffolds in Alzheimer's Disease: Therapeutic Potential, Mechanism, and Clinical Aspects. [PDF]

open access: yesBiomed Res Int
Alzheimer′s disease (AD) is a multifactorial neurodegenerative disorder characterized by progressive cognitive impairment, amyloid‐β deposition, tau pathology, oxidative stress, neuroinflammation, and dysfunction of synapses. Current therapeutic options are largely symptomatic and lack disease‐modifying efficacy.
Singh A, Sahu SK, Sah AK.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy